This Review provides the structural and cellular foundations for understanding the multistep SARS-CoV-2 entry process.
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Breaking newsCOVID-19Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
In this article the authors analysed the development of anti-SARS-CoV-2 antibody and T cell responses in previously infected (recovered) or uninfected (naive) individuals that received mRNA vaccines to SARS-CoV-2. -
Breaking newsCOVID-19A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries
The aim of this study was to estimate weather-dependent signatures in the early phase of the pandemic, while controlling for socio-economic factors and non-pharmaceutical interventions. -
Breaking newsCOVID-19
COVID-19 is associated with distinct myopathic features in the diaphragm of critically ill patients
The authors of this study aimed to characterise myofiber structure in the diaphragm of critically ill patients with COVID-19. -
Breaking newsCOVID-19Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial
The objective of this study was to determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19. -
Breaking newsCOVID-19
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
Evaluation of the effects of therapeutic-dose low-molecular-weight heparin vs institutional standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19. -
Breaking newsCOVID-19
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021
The objective of this study was to assess reports of GBS received in the Vaccine Adverse Event Reporting System (VAERS) following Ad26.COV2.S vaccination. -
Breaking newsCOVID-19
Association Between Risk of COVID-19 Infection in Nonimmune Individuals and COVID-19 Immunity in Their Family Members
The objective of this study was to investigate the association between risk of COVID-19 in nonimmune individuals and the number of their family members with known immunity acquired from a previous COVID-19 infection or full vaccination (2 vaccine doses). -
Breaking newsCOVID-19Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 The ACTIV-4B Randomized Clinical Trial
The objective of this study was to assess whether anticoagulant or antiplatelet therapy can safely reduce major adverse cardiopulmonary outcomes among symptomatic but clinically stable outpatients with COVID-19. -
Breaking newsCOVID-19Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review
The objective of this study was to estimate organ system–specific frequency and evolution of PASC. -
Breaking newsCOVID-19
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study
The authors of this study aimed to estimate the frequency of COVID-19 hospitalisation or death in people who received at least one vaccine dose and characterise these individuals. -
Breaking newsCOVID-19
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
In this retrospective cohort study the authors aimed to evaluate overall and variant-specific effectiveness of BNT162b2 against SARS-CoV-2 infections and COVID-19-related hospital admissions by time since vaccination among members of a large US healthcare system. -
Breaking newsCOVID-19
All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study
This study included prospective data from a large mental healthcare provider in London, UK, with deaths from 2019 to 2020, used to assess age and gender-standardised mortality ratios (SMRs) across nine psychiatric conditions and by ethnicity. -
Breaking newsCOVID-19
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
In this study, the authors aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020. -
Breaking newsCOVID-19
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study
In this retrospective surveillance study, the authors provide estimates of the number of SARS-CoV-2 infections and COVID-19-related admissions to hospital (ie, hospitalisations) and deaths averted by the nationwide vaccination campaign.